Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer

Liver diseases is a growing epidemic worldwide. If unresolved, liver fibrosis develops and can lead to cirrhosis and clinical decompensation. Around 5% of cirrhotic liver diseased patients develop hepatocellular carcinoma (HCC), which in its advanced stages has limited therapeutic options and negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Reebye, Vikash, Huang, Kai-Wen, Lin, Vivian, Jarvis, Sheba, Cutilas, Pedro, Dorman, Stephanie, Ciriello, Simona, Andrikakou, Pinelopi, Voutila, Jon, Saetrom, Pal, Mintz, Paul J, Reccia, Isabella, Rossi, John J, Huber, Hans, Habib, Robert, Kostomitsopoulos, Nikos, Blakey, David, Habib, Nagy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013054/
https://www.ncbi.nlm.nih.gov/pubmed/29511346
http://dx.doi.org/10.1038/s41388-018-0126-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013054/
https://www.ncbi.nlm.nih.gov/pubmed/29511346
http://dx.doi.org/10.1038/s41388-018-0126-2

Ejemplares similares